ACH (Accendra Health) Cyclically Adjusted Revenue per Share: $142.45 (As of Mar. 2026)


ACH Accendra Health Inc ACH
61 GF Score
Price $3.64
GF Value $5.02
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Accendra Health Cyclically Adjusted Revenue per Share?

Accendra Health ACH +1.39% 61 Cyclically Adjusted Revenue per Share is $142.45 as of Mar. 2026. GuruFocus rates ACH with a GF Score™ of 61/100 and a GF Value™ of $5.02 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Accendra Health's adjusted revenue per share for the three months ended in Mar. 2026 was $8.214. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $142.45 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Accendra Health's average Cyclically Adjusted Revenue Growth Rate was -8.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -6.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -2.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Accendra Health was 11.20% per year. The lowest was -6.10% per year. And the median was 5.40% per year.

As of today (2026-07-07), Accendra Health's current stock price is $3.64. Accendra Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $142.45. Accendra Health's Cyclically Adjusted PS Ratio of today is 0.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Accendra Health was 0.29. The lowest was 0.01. And the median was 0.11.


Accendra Health  (NYSE:ACH) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Accendra Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.64/142.45
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Accendra Health was 0.29. The lowest was 0.01. And the median was 0.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Accendra Health Cyclically Adjusted Revenue per Share Related Terms


Accendra Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Accendra Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Cyclically Adjusted Revenue per Share Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 168.78 174.62 164.91 155.56 144.40

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.83 152.80 149.32 144.40 142.45

ACH vs FOCL, YI, COSM: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Accendra Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Accendra Health's Cyclically Adjusted PS Ratio falls into.


ACH
61GF Score
Accendra Health Inc ACH
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accendra Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.214/330.2130*330.2130
=8.214

Current CPI (Mar. 2026) = 330.2130.

Accendra Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 40.384 241.018 55.329
201609 39.590 241.428 54.149
201612 39.370 241.432 53.847
201703 38.801 243.801 52.553
201706 37.852 244.955 51.027
201709 38.997 246.819 52.173
201712 39.848 246.524 53.375
201803 39.563 249.554 52.350
201806 41.143 251.989 53.915
201809 41.242 252.439 53.948
201812 35.334 251.233 46.442
201903 38.937 254.202 50.580
201906 39.741 256.143 51.233
201909 38.193 256.759 49.119
201912 36.029 256.974 46.297
202003 35.045 258.115 44.834
202006 29.573 257.797 37.880
202009 35.913 260.280 45.562
202012 33.219 260.474 42.113
202103 32.797 264.877 40.887
202106 32.840 271.696 39.913
202109 32.942 274.310 39.655
202112 32.576 278.802 38.583
202203 31.663 287.504 36.367
202206 32.767 296.311 36.516
202209 32.682 296.808 36.360
202212 33.464 296.797 37.232
202303 33.559 301.836 36.714
202306 33.815 305.109 36.597
202309 34.011 307.789 36.489
202312 -67.378 306.746 -72.533
202403 34.234 312.332 36.194
202406 8.607 314.175 9.046
202409 8.752 315.301 9.166
202412 9.027 315.605 9.445
202503 34.062 319.799 35.171
202506 8.864 322.561 9.074
202509 9.022 324.800 9.172
202512 9.282 324.054 9.458
202603 8.214 330.213 8.214

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $142.45 mean?
Accendra Health (ACH) has a Cyclically Adjusted Revenue per Share of $142.45 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Accendra Health and its competitors.
Is Accendra Health's Cyclically Adjusted Revenue per Share too high?
Accendra Health's current Cyclically Adjusted Revenue per Share is $142.45. Overall, Accendra Health has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Cyclically Adjusted Revenue per Share compare to FOCL and YI?
Accendra Health's Cyclically Adjusted Revenue per Share of $142.45 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Accendra Health and its competitors. Accendra Health's current Cyclically Adjusted Revenue per Share is $142.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.02, compared to a current price of $3.64 — trading 27.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $142.45. Accendra Health's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Accendra Health (ACH), the current Cyclically Adjusted Revenue per Share is $142.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.64 is trading 27.5% below its estimated GF Value™ of $5.02. GuruFocus considers Accendra Health to be Modestly Undervalued.

Key valuation signals for ACH:

  • Cyclically Adjusted Revenue per Share: $142.45
  • GF Value™: $5.02 vs. price of $3.64 (27.5% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
61GF Score

Get the complete analysis for ACH

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.64
Price
$5.02
GF Value